1. An update review of emerging small-molecule therapeutic options for COVID-19.
- Author
-
Tian, Dengke, Liu, Yuzhi, Liang, Chengyuan, Xin, Liang, Xie, Xiaolin, Zhang, Dezhu, Wan, Minge, Li, Han, Fu, Xueqi, Liu, Hong, and Cao, Wenqiang
- Subjects
- *
COVID-19 , *RNA replicase , *COVID-19 pandemic , *DIHYDROOROTATE dehydrogenase , *SARS-CoV-2 , *GRANZYMES - Abstract
[Display omitted] • The present review showcases the major pharmaceutical drug targets that can be used to fight against the SARS-CoV-2 pandemic. • Nonstructural protein inhibitors are essential in preventing host cell entry of coronaviruses and are thoroughly discussed. • Potential SARS-CoV-2 drug targets, including their structures, effects and potential impacts, are reviewed. • Small-molecule therapeutics and their modes of disease suppression are explained in detail. The SARS-CoV-2 outbreak and pandemic that began near the end of 2019 has posed a challenge to global health. At present, many candidate small-molecule therapeutics have been developed that can inhibit both the infection and replication of SARS-CoV-2 and even potentially relieve cytokine storms and other related complications. Meanwhile, host-targeted drugs that inhibit cellular transmembrane serine protease (TMPRSS2) can prevent SARS-CoV-2 from entering cells, and its combination with chloroquine and dihydroorotate dehydrogenase (DHODH) inhibitors can limit the spread of SARS-CoV-2 and reduce the morbidity and mortality of patients with COVID-19. The present article provides an overview of these small-molecule therapeutics based on insights from medicinal chemistry research and focuses on RNA-dependent RNA polymerase (RdRp) inhibitors, such as the nucleoside analogues remdesivir, favipiravir and ribavirin. This review also covers inhibitors of 3C-like protease (3CLpro), papain-like protease (PLpro) and other potentially innovative active ingredient molecules, describing their potential targets, activities, clinical status and side effects. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF